According to this study, Global Antibacterial Therapeutic market size will reach US$ 139800 million by 2031.

Global Antibacterial Therapeutic Market Size and Outlook 2025-31

According to this study, the global Antibacterial Therapeutic market size will reach US$ 139800 million by 2031. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Antibacterial Therapeutic Industry Forecast looks at past sales and reviews total world Antibacterial Therapeutic sales in 2024, providing a comprehensive analysis by region and market sector of projected Antibacterial Therapeutic sales for 2025 through 2031. With Antibacterial Therapeutic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Antibacterial Therapeutic industry. This Insight Report provides a comprehensive analysis of the global Antibacterial Therapeutic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Antibacterial Therapeutic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Antibacterial Therapeutic market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Antibacterial Therapeutic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Antibacterial Therapeutic. This report presents a comprehensive overview, market shares, and growth opportunities of Antibacterial Therapeutic market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Penicillins &nbsp;&nbsp;&nbsp; Cephalosporins &nbsp;&nbsp;&nbsp; Quinolone &nbsp;&nbsp;&nbsp; Aminoglycosides &nbsp;&nbsp;&nbsp; Monobactams &nbsp;&nbsp;&nbsp; Carbapenems &nbsp;&nbsp;&nbsp; Macrolides &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Oral &nbsp;&nbsp;&nbsp; Topical &nbsp;&nbsp;&nbsp; Parenteral &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Abbott &nbsp;&nbsp;&nbsp; Daiichi Sankyo &nbsp;&nbsp;&nbsp; Pfizer &nbsp;&nbsp;&nbsp; Takeda &nbsp;&nbsp;&nbsp; Eli Lilly &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; Sanofi &nbsp;&nbsp;&nbsp; AstraZeneca &nbsp;&nbsp;&nbsp; Bayer &nbsp;&nbsp;&nbsp; Merck

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Antibacterial Therapeutic Market Size (2020-2031) &nbsp;2.1.2 Antibacterial Therapeutic Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Antibacterial Therapeutic by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Antibacterial Therapeutic Segment by Type &nbsp;2.2.1 Penicillins &nbsp;2.2.2 Cephalosporins &nbsp;2.2.3 Quinolone &nbsp;2.2.4 Aminoglycosides &nbsp;2.2.5 Monobactams &nbsp;2.2.6 Carbapenems &nbsp;2.2.7 Macrolides &nbsp;2.2.8 Others &nbsp;2.3 Antibacterial Therapeutic Market Size by Type &nbsp;2.3.1 Antibacterial Therapeutic Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Antibacterial Therapeutic Market Size Market Share by Type (2020-2025) &nbsp;2.4 Antibacterial Therapeutic Segment by Application &nbsp;2.4.1 Oral &nbsp;2.4.2 Topical &nbsp;2.4.3 Parenteral &nbsp;2.4.4 Others &nbsp;2.5 Antibacterial Therapeutic Market Size by Application &nbsp;2.5.1 Antibacterial Therapeutic Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Antibacterial Therapeutic Market Size Market Share by Application (2020-2025) 3 Antibacterial Therapeutic Market Size by Player &nbsp;3.1 Antibacterial Therapeutic Market Size Market Share by Player &nbsp;3.1.1 Global Antibacterial Therapeutic Revenue by Player (2020-2025) &nbsp;3.1.2 Global Antibacterial Therapeutic Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Antibacterial Therapeutic Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Antibacterial Therapeutic by Region &nbsp;4.1 Antibacterial Therapeutic Market Size by Region (2020-2025) &nbsp;4.2 Global Antibacterial Therapeutic Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Antibacterial Therapeutic Market Size Growth (2020-2025) &nbsp;4.4 APAC Antibacterial Therapeutic Market Size Growth (2020-2025) &nbsp;4.5 Europe Antibacterial Therapeutic Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Antibacterial Therapeutic Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Antibacterial Therapeutic Market Size by Country (2020-2025) &nbsp;5.2 Americas Antibacterial Therapeutic Market Size by Type (2020-2025) &nbsp;5.3 Americas Antibacterial Therapeutic Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Antibacterial Therapeutic Market Size by Region (2020-2025) &nbsp;6.2 APAC Antibacterial Therapeutic Market Size by Type (2020-2025) &nbsp;6.3 APAC Antibacterial Therapeutic Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Antibacterial Therapeutic Market Size by Country (2020-2025) &nbsp;7.2 Europe Antibacterial Therapeutic Market Size by Type (2020-2025) &nbsp;7.3 Europe Antibacterial Therapeutic Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Antibacterial Therapeutic by Region (2020-2025) &nbsp;8.2 Middle East & Africa Antibacterial Therapeutic Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Antibacterial Therapeutic Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Antibacterial Therapeutic Market Forecast &nbsp;10.1 Global Antibacterial Therapeutic Forecast by Region (2026-2031) &nbsp;10.1.1 Global Antibacterial Therapeutic Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Antibacterial Therapeutic Forecast &nbsp;10.1.3 APAC Antibacterial Therapeutic Forecast &nbsp;10.1.4 Europe Antibacterial Therapeutic Forecast &nbsp;10.1.5 Middle East & Africa Antibacterial Therapeutic Forecast &nbsp;10.2 Americas Antibacterial Therapeutic Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Antibacterial Therapeutic Forecast &nbsp;10.2.2 Canada Market Antibacterial Therapeutic Forecast &nbsp;10.2.3 Mexico Market Antibacterial Therapeutic Forecast &nbsp;10.2.4 Brazil Market Antibacterial Therapeutic Forecast &nbsp;10.3 APAC Antibacterial Therapeutic Forecast by Region (2026-2031) &nbsp;10.3.1 China Antibacterial Therapeutic Market Forecast &nbsp;10.3.2 Japan Market Antibacterial Therapeutic Forecast &nbsp;10.3.3 Korea Market Antibacterial Therapeutic Forecast &nbsp;10.3.4 Southeast Asia Market Antibacterial Therapeutic Forecast &nbsp;10.3.5 India Market Antibacterial Therapeutic Forecast &nbsp;10.3.6 Australia Market Antibacterial Therapeutic Forecast &nbsp;10.4 Europe Antibacterial Therapeutic Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Antibacterial Therapeutic Forecast &nbsp;10.4.2 France Market Antibacterial Therapeutic Forecast &nbsp;10.4.3 UK Market Antibacterial Therapeutic Forecast &nbsp;10.4.4 Italy Market Antibacterial Therapeutic Forecast &nbsp;10.4.5 Russia Market Antibacterial Therapeutic Forecast &nbsp;10.5 Middle East & Africa Antibacterial Therapeutic Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Antibacterial Therapeutic Forecast &nbsp;10.5.2 South Africa Market Antibacterial Therapeutic Forecast &nbsp;10.5.3 Israel Market Antibacterial Therapeutic Forecast &nbsp;10.5.4 Turkey Market Antibacterial Therapeutic Forecast &nbsp;10.6 Global Antibacterial Therapeutic Forecast by Type (2026-2031) &nbsp;10.7 Global Antibacterial Therapeutic Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Antibacterial Therapeutic Forecast 11 Key Players Analysis &nbsp;11.1 Abbott &nbsp;11.1.1 Abbott Company Information &nbsp;11.1.2 Abbott Antibacterial Therapeutic Product Offered &nbsp;11.1.3 Abbott Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Abbott Main Business Overview &nbsp;11.1.5 Abbott Latest Developments &nbsp;11.2 Daiichi Sankyo &nbsp;11.2.1 Daiichi Sankyo Company Information &nbsp;11.2.2 Daiichi Sankyo Antibacterial Therapeutic Product Offered &nbsp;11.2.3 Daiichi Sankyo Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Daiichi Sankyo Main Business Overview &nbsp;11.2.5 Daiichi Sankyo Latest Developments &nbsp;11.3 Pfizer &nbsp;11.3.1 Pfizer Company Information &nbsp;11.3.2 Pfizer Antibacterial Therapeutic Product Offered &nbsp;11.3.3 Pfizer Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Pfizer Main Business Overview &nbsp;11.3.5 Pfizer Latest Developments &nbsp;11.4 Takeda &nbsp;11.4.1 Takeda Company Information &nbsp;11.4.2 Takeda Antibacterial Therapeutic Product Offered &nbsp;11.4.3 Takeda Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Takeda Main Business Overview &nbsp;11.4.5 Takeda Latest Developments &nbsp;11.5 Eli Lilly &nbsp;11.5.1 Eli Lilly Company Information &nbsp;11.5.2 Eli Lilly Antibacterial Therapeutic Product Offered &nbsp;11.5.3 Eli Lilly Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Eli Lilly Main Business Overview &nbsp;11.5.5 Eli Lilly Latest Developments &nbsp;11.6 Novartis &nbsp;11.6.1 Novartis Company Information &nbsp;11.6.2 Novartis Antibacterial Therapeutic Product Offered &nbsp;11.6.3 Novartis Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Novartis Main Business Overview &nbsp;11.6.5 Novartis Latest Developments &nbsp;11.7 Sanofi &nbsp;11.7.1 Sanofi Company Information &nbsp;11.7.2 Sanofi Antibacterial Therapeutic Product Offered &nbsp;11.7.3 Sanofi Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Sanofi Main Business Overview &nbsp;11.7.5 Sanofi Latest Developments &nbsp;11.8 AstraZeneca &nbsp;11.8.1 AstraZeneca Company Information &nbsp;11.8.2 AstraZeneca Antibacterial Therapeutic Product Offered &nbsp;11.8.3 AstraZeneca Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 AstraZeneca Main Business Overview &nbsp;11.8.5 AstraZeneca Latest Developments &nbsp;11.9 Bayer &nbsp;11.9.1 Bayer Company Information &nbsp;11.9.2 Bayer Antibacterial Therapeutic Product Offered &nbsp;11.9.3 Bayer Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Bayer Main Business Overview &nbsp;11.9.5 Bayer Latest Developments &nbsp;11.10 Merck &nbsp;11.10.1 Merck Company Information &nbsp;11.10.2 Merck Antibacterial Therapeutic Product Offered &nbsp;11.10.3 Merck Antibacterial Therapeutic Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.10.4 Merck Main Business Overview &nbsp;11.10.5 Merck Latest Developments 12 Research Findings and Conclusion

Report	Global Antibacterial Therapeutic Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI24771

Buyer Information

Order Summary